This is the authors' abstract. We don't add key points for this paper.
Background Late-life depression (LLD) is challenging to treat, and when left untreated may be deleterious to cognitive functioning. Cognitive control deficits (CCD) are both particularly common in LLD and associated with poor clinical outcomes including nonresponse to gold standard antidepressant (SSRI/SNRI) therapies. In previous trials, digital therapeutics targeting CCD have shown preliminary efficacy in enhancing both cognitive functions and mood in LLD, yet the hypothesized mechanisms that these interventions target and change remain theoretical. Here we report results from a recently completed, double-blind, randomized pilot study using a digital therapeutic program, NeuroFlex, designed to increase neuroplasticity in the cognitive control network (CCN), a functionally linked system of brain regions including the dorsolateral prefrontal cortex, anterior cingulate cortex (ACC), and dorsal parietal cortex (DPC) believed to underlie CCD. We hypothesized that NeuroFlex would increase resting state functional connectivity within and between the CCN and other essential neural networks in LLD, more than an active, expectancy matched digital control condition. Methods 20 older adults with LLD enrolled in a 6-week randomized controlled trial (RCT) contrasting the effects of NeuroFlex ( n = 9) with a control condition ( n = 11) matched for tablet use, duration, and study personnel contact on pre- and post-6-week fMRI. Results Following the 6-week randomized controlled trial (RCT), whole-brain atlas-based region of interest (ROI) to-ROI analysis with false discovery rate (FDR) correction revealed that NeuroFlex resulted in increased connectivity between the medial prefrontal cortex (mPFC) and left insula compared with the control condition. Seed-to-voxel analyses on regions of interest within the CCN revealed that there were significant group x time interaction effects in the functional connectivity between the dorsal anterior cingulate cortex (ACC) and the right dorsal parietal cortex (DPC) with connectivity significantly increased post vs. preintervention in the intervention group compared with the control group (with FDR correction). By contrast, clinical change in depression symptom severity favoring NeuroFlex over the control condition did not reach statistical significance. Discussion These preliminary results provide evidence that NeuroFlex not only modified our targeted CCN, but also the reward and salience networks in LLD. While the current analyses are limited by a small neuroimaging sample, this project is ongoing and continued data collection will help determine whether these network changes are associated with clinical improvement.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Manning et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: